People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Biotechnology, Other Technology, Other, Pharmaceuticals, Crypto / Web3
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ivenix, Inc. | — | Biotechnology | Series B | $82.9M | $396.9M | 2017 |
| Cureatr Inc. | — | Other Technology | Series A | $28.6M | $25.1M | 2019 |
| Banro Corp | — | Other | Series B | $18.1M | $278.7M | 2013 |
| Zoomcar Holdings, Inc. | — | Other | Series A | $14.6M | $21.6M | 2024 |
| Abide Therapeutics, Inc. | — | Pharmaceuticals | Seed | $2.2M | $83.7M | 2011 |
| Blockchain Technologies, Inc. | — | Crypto / Web3 | Seed | $2.1M | $41.5M | 2021 |
| Etruscan Resources Inc. | — | Other | Pre-Seed | $427K | $9.9M | 2010 |
| Avingtrans PLC | — | Other | Pre-Seed | $104K | $587K | 2023 |
John Clarke at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Clarke on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brandon Hull | 2 | 5 |
| Todd Pietri | 1 | 13 |
| Ketan Patel | 1 | 10 |
| Wei Li | 1 | 7 |
| James Bradley | 1 | 6 |
| Rick Van Nieuwenhuyse | 1 | 6 |
| John K. Clarke | 1 | 5 |
| Wayne B. Weisman | 1 | 5 |
| Sachin Gupta | 1 | 5 |
| Sally Eyre | 1 | 4 |
| John Wu | 1 | 4 |
| Alan Ezekowitz | 1 | 4 |
| Stephen King | 1 | 4 |
| Bharath Ganesan | 1 | 3 |
| Evelyn D'An | 1 | 3 |
| Richard T. Lachcik | 1 | 2 |
| Joseph Mayer | 1 | 2 |
| Colin J. Foster | 1 | 2 |
| Mohan Ananda | 1 | 2 |
| Charles Hadley | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.